Pharma-Bio Serv (PBSV) Total Liabilities (2010 - 2026)

Pharma-Bio Serv's Total Liabilities history runs 17 years deep, the most recent figure standing at $1.0 million for Q2 2026.

• Total Liabilities for Q2 2026 came in at $1.0 million, down 41.29% year-over-year; the trailing twelve-month figure through Apr 2026 was $1.0 million (down 41.29% YoY), and the FY2025 annual result was $1.7 million, down 32.52% from the prior year.
• Total Liabilities came in at $1.0 million for Q2 2026 at Pharma-Bio Serv, down from $3.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $5.1 million in Q1 2024 to a low of $1.0 million in Q2 2026.
• A 5-year average of $3.3 million and a median of $3.8 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities tumbled 47.86% in 2022 and gained 29.79% in 2024, its largest moves.
• Over 5 years, Total Liabilities stood at $4.1 million in 2022, then retreated by 7.77% to $3.8 million in 2023, then slumped by 31.74% to $2.6 million in 2024, then tumbled by 32.52% to $1.7 million in 2025, then slumped by 39.89% to $1.0 million in 2026.
• The last three Total Liabilities figures came in at $1.0 million (Q2 2026), $3.3 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.